Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Chemotherapy-related cognitive impairment in older patients with cancer.

Loh KP, Janelsins MC, Mohile SG, Holmes HM, Hsu T, Inouye SK, Karuturi MS, Kimmick GG, Lichtman SM, Magnuson A, Whitehead MI, Wong ML, Ahles TA.

J Geriatr Oncol. 2016 Jul;7(4):270-80. doi: 10.1016/j.jgo.2016.04.008. Epub 2016 Jul 5. Review.

2.

Emotional acceptance, inflammation, and sickness symptoms across the first two years following breast cancer diagnosis.

Reed RG, Weihs KL, Sbarra DA, Breen EC, Irwin MR, Butler EA.

Brain Behav Immun. 2016 Aug;56:165-74. doi: 10.1016/j.bbi.2016.02.018. Epub 2016 Feb 23.

PMID:
26916219
3.

Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report.

Yennurajalingam S, Williams JL, Chisholm G, Bruera E.

Oncologist. 2016 Mar;21(3):384-90. doi: 10.1634/theoncologist.2014-0260. Epub 2016 Feb 17.

PMID:
26888692
4.

Exercise, inflammation, and fatigue in cancer survivors.

LaVoy EC, Fagundes CP, Dantzer R.

Exerc Immunol Rev. 2016;22:82-93.

5.

Localized External Beam Radiation Therapy (EBRT) to the Pelvis Induces Systemic IL-1Beta and TNF-Alpha Production: Role of the TNF-Alpha Signaling in EBRT-Induced Fatigue.

McDonald TL, Hung AY, Thomas CR, Wood LJ.

Radiat Res. 2016 Jan;185(1):4-12. doi: 10.1667/RR14072.1. Epub 2015 Dec 31.

PMID:
26720802
6.

Review complementary and integrative interventions for cancer-related cognitive changes.

Myers JS.

Asia Pac J Oncol Nurs. 2015 Oct-Dec;2(4):215-226. Epub 2015 Nov 30.

7.

C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.

Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C.

PLoS One. 2015 Dec 30;10(12):e0143080. doi: 10.1371/journal.pone.0143080. eCollection 2015. Review.

8.

Sickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expression.

Vichaya EG, Molkentine JM, Vermeer DW, Walker AK, Feng R, Holder G, Luu K, Mason RM, Saligan L, Heijnen CJ, Kavelaars A, Mason KA, Lee JH, Dantzer R.

Behav Brain Res. 2016 Jan 15;297:241-50. doi: 10.1016/j.bbr.2015.10.024. Epub 2015 Oct 22.

PMID:
26475509
9.

Behavioral Symptoms after Breast Cancer Treatment: A Biobehavioral Approach.

Fagundes C, LeRoy A, Karuga M.

J Pers Med. 2015 Aug 3;5(3):280-95. doi: 10.3390/jpm5030280. Review.

10.

Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study.

Aboalela N, Lyon D, Elswick RK Jr, Kelly DL, Brumelle J, Bear HD, Jackson-Cook C.

PLoS One. 2015 Jul 15;10(7):e0133380. doi: 10.1371/journal.pone.0133380. eCollection 2015.

11.

Symptom clusters and quality of life in China patients with lung cancer undergoing chemotherapy.

Wang D, Fu J.

Afr Health Sci. 2014 Mar;14(1):49-55. doi: 10.4314/ahs.v14i1.8.

12.

Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Schrepf A, Lutgendorf SK, Pyter LM.

Brain Behav Immun. 2015 Oct;49:1-17. doi: 10.1016/j.bbi.2015.04.010. Epub 2015 May 6. Review.

PMID:
25958011
13.

Mechanisms of chemotherapy-induced behavioral toxicities.

Vichaya EG, Chiu GS, Krukowski K, Lacourt TE, Kavelaars A, Dantzer R, Heijnen CJ, Walker AK.

Front Neurosci. 2015 Apr 21;9:131. doi: 10.3389/fnins.2015.00131. eCollection 2015. Review.

15.

Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression.

Cruz FM, Munhoz BA, Alves BC, Gehrke FS, Fonseca FL, Kuniyoshi RK, Cubero D, Peppone LJ, Del Giglio A.

Clin Transl Med. 2015 Feb 14;4:4. doi: 10.1186/s40169-015-0051-8. eCollection 2015.

16.

Potential factors associated with perceived cognitive impairment in breast cancer survivors.

Myers JS, Wick JA, Klemp J.

Support Care Cancer. 2015 Nov;23(11):3219-28. doi: 10.1007/s00520-015-2708-7. Epub 2015 Apr 3.

17.

Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy.

Wang XM, Walitt B, Saligan L, Tiwari AF, Cheung CW, Zhang ZJ.

Cytokine. 2015 Mar;72(1):86-96. doi: 10.1016/j.cyto.2014.12.006. Epub 2015 Jan 5. Review.

18.

Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.

Shi Q, Wang XS, Li G, Shah ND, Orlowski RZ, Williams LA, Mendoza TR, Cleeland CS.

Cancer. 2015 Apr 1;121(7):1138-46. doi: 10.1002/cncr.29154. Epub 2014 Dec 2.

19.

Cancer-related and treatment-related fatigue.

Wang XS, Woodruff JF.

Gynecol Oncol. 2015 Mar;136(3):446-52. doi: 10.1016/j.ygyno.2014.10.013. Epub 2014 Oct 23. Review.

20.

Cancer-related fatigue--mechanisms, risk factors, and treatments.

Bower JE.

Nat Rev Clin Oncol. 2014 Oct;11(10):597-609. doi: 10.1038/nrclinonc.2014.127. Epub 2014 Aug 12. Review.

Items per page

Supplemental Content

Write to the Help Desk